Non Interventional Study For Patients Treated With Somavert®
Non Interventional Study For Patients Treated With Somavert®
This open-label, national, prospective, observational, non-interventional, multi-center, post
 marketing surveillance study was performed in order to examine the efficacy and safety of
 Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related
 co-morbidities.
Non probability samples
Inclusion Criteria:

 -  Subjects with diagnosed acromegaly who were already being treated with Somavert® or
 were to start treatment with Somavert® were included in the study.

 Exclusion Criteria:

 -  Subjects treated with an investigational drug for treatment of acromegaly.

 -  Subjects with symptoms such visual field loss, cranial nerve palsies or intracranial
 hypertension, indicating need for surgery.

 -  Women who were pregnant or lactating.